Boston Globe
Boston Globe
And the $68 billion acquisition of Wyeth Pharmaceuticals, completed last week, gave rival drug company Pfizer Inc. a foothold in the vaccine business. ...
and more »
Thursday, October 22, 2009
The quest for an H1N1 vaccine has been good business for some firms - Boston Globe
Boston Globe
Boston Globe
And the $68 billion acquisition of Wyeth Pharmaceuticals, completed last week, gave rival drug company Pfizer Inc. a foothold in the vaccine business. ...
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment